FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113884612> ?p ?o ?g. }

• W2113884612 endingPage "e1001659" @default.
• W2113884612 startingPage "e1001659" @default.
• W2113884612 abstract "Cutaneous nevi are suggested to be hormone-related. We hypothesized that the number of cutaneous nevi might be a phenotypic marker of plasma hormone levels and predict subsequent breast cancer risk.We followed 74,523 female nurses for 24 y (1986-2010) in the Nurses' Health Study and estimate the relative risk of breast cancer according to the number of cutaneous nevi. We adjusted for the known breast cancer risk factors in the models. During follow-up, a total of 5,483 invasive breast cancer cases were diagnosed. Compared to women with no nevi, women with more cutaneous nevi had higher risks of breast cancer (multivariable-adjusted hazard ratio, 1.04, 95% confidence interval [CI], 0.98-1.10 for 1-5 nevi; 1.15, 95% CI, 1.00-1.31 for 6-14 nevi, and 1.35, 95% CI, 1.04-1.74 for 15 or more nevi; p for continuous trend = 0.003). Over 24 y of follow-up, the absolute risk of developing breast cancer increased from 8.48% for women without cutaneous nevi to 8.82% (95% CI, 8.31%-9.33%) for women with 1-5 nevi, 9.75% (95% CI, 8.48%-11.11%) for women with 6-14 nevi, and 11.4% (95% CI, 8.82%-14.76%) for women with 15 or more nevi. The number of cutaneous nevi was associated with increased risk of breast cancer only among estrogen receptor (ER)-positive tumors (multivariable-adjusted hazard ratio per five nevi, 1.09, 95% CI, 1.02-1.16 for ER+/progesterone receptor [PR]-positive tumors; 1.08, 95% CI, 0.94-1.24 for ER+/PR- tumors; and 0.99, 95% CI, 0.86-1.15 for ER-/PR- tumors). Additionally, we tested plasma hormone levels according to the number of cutaneous nevi among a subgroup of postmenopausal women without postmenopausal hormone use (n = 611). Postmenopausal women with six or more nevi had a 45.5% higher level of free estradiol and a 47.4% higher level of free testosterone compared to those with no nevi (p for trend = 0.001 for both). Among a subgroup of 362 breast cancer cases and 611 matched controls with plasma hormone measurements, the multivariable-adjusted odds ratio for every five nevi attenuated from 1.25 (95% CI, 0.89-1.74) to 1.16 (95% CI, 0.83-1.64) after adjusting for plasma hormone levels. Key limitations in this study are that cutaneous nevi were self-counted in our cohort and that the study was conducted in white individuals, and thus the findings do not necessarily apply to other populations.Our results suggest that the number of cutaneous nevi may reflect plasma hormone levels and predict breast cancer risk independently of previously known factors." @default.
• W2113884612 created "2016-06-24" @default.
• W2113884612 creator A5008373933 @default.
• W2113884612 creator A5014551852 @default.
• W2113884612 creator A5031168277 @default.
• W2113884612 creator A5050902669 @default.
• W2113884612 creator A5062861253 @default.
• W2113884612 creator A5072036320 @default.
• W2113884612 date "2014-06-10" @default.
• W2113884612 modified "2023-10-07" @default.
• W2113884612 title "Association between Cutaneous Nevi and Breast Cancer in the Nurses' Health Study: A Prospective Cohort Study" @default.
• W2113884612 cites W1511930757 @default.
• W2113884612 cites W1861209549 @default.
• W2113884612 cites W1981843591 @default.
• W2113884612 cites W1998977605 @default.
• W2113884612 cites W2026122583 @default.
• W2113884612 cites W2034280105 @default.
• W2113884612 cites W2050826693 @default.
• W2113884612 cites W2054339472 @default.
• W2113884612 cites W2075198332 @default.
• W2113884612 cites W2087540265 @default.
• W2113884612 cites W2104792303 @default.
• W2113884612 cites W2105684250 @default.
• W2113884612 cites W2115379774 @default.
• W2113884612 cites W2122100237 @default.
• W2113884612 cites W2129140467 @default.
• W2113884612 cites W2131602910 @default.
• W2113884612 cites W2136244587 @default.
• W2113884612 cites W2161628074 @default.
• W2113884612 cites W2272676565 @default.
• W2113884612 cites W2315152040 @default.
• W2113884612 cites W2408721985 @default.
• W2113884612 doi "https://doi.org/10.1371/journal.pmed.1001659" @default.
• W2113884612 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4051600" @default.
• W2113884612 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24915186" @default.
• W2113884612 hasPublicationYear "2014" @default.
• W2113884612 type Work @default.
• W2113884612 sameAs 2113884612 @default.
• W2113884612 citedByCount "17" @default.
• W2113884612 countsByYear W21138846122014 @default.
• W2113884612 countsByYear W21138846122015 @default.
• W2113884612 countsByYear W21138846122016 @default.
• W2113884612 countsByYear W21138846122017 @default.
• W2113884612 countsByYear W21138846122019 @default.
• W2113884612 countsByYear W21138846122020 @default.
• W2113884612 countsByYear W21138846122021 @default.
• W2113884612 countsByYear W21138846122022 @default.
• W2113884612 crossrefType "journal-article" @default.
• W2113884612 hasAuthorship W2113884612A5008373933 @default.
• W2113884612 hasAuthorship W2113884612A5014551852 @default.
• W2113884612 hasAuthorship W2113884612A5031168277 @default.
• W2113884612 hasAuthorship W2113884612A5050902669 @default.
• W2113884612 hasAuthorship W2113884612A5062861253 @default.
• W2113884612 hasAuthorship W2113884612A5072036320 @default.
• W2113884612 hasBestOaLocation W21138846121 @default.
• W2113884612 hasConcept C121608353 @default.
• W2113884612 hasConcept C126322002 @default.
• W2113884612 hasConcept C143998085 @default.
• W2113884612 hasConcept C148759681 @default.
• W2113884612 hasConcept C16005928 @default.
• W2113884612 hasConcept C188816634 @default.
• W2113884612 hasConcept C207103383 @default.
• W2113884612 hasConcept C29456083 @default.
• W2113884612 hasConcept C44249647 @default.
• W2113884612 hasConcept C530470458 @default.
• W2113884612 hasConcept C71924100 @default.
• W2113884612 hasConcept C82789193 @default.
• W2113884612 hasConceptScore W2113884612C121608353 @default.
• W2113884612 hasConceptScore W2113884612C126322002 @default.
• W2113884612 hasConceptScore W2113884612C143998085 @default.
• W2113884612 hasConceptScore W2113884612C148759681 @default.
• W2113884612 hasConceptScore W2113884612C16005928 @default.
• W2113884612 hasConceptScore W2113884612C188816634 @default.
• W2113884612 hasConceptScore W2113884612C207103383 @default.
• W2113884612 hasConceptScore W2113884612C29456083 @default.
• W2113884612 hasConceptScore W2113884612C44249647 @default.
• W2113884612 hasConceptScore W2113884612C530470458 @default.
• W2113884612 hasConceptScore W2113884612C71924100 @default.
• W2113884612 hasConceptScore W2113884612C82789193 @default.
• W2113884612 hasIssue "6" @default.
• W2113884612 hasLocation W21138846121 @default.
• W2113884612 hasLocation W21138846122 @default.
• W2113884612 hasLocation W21138846123 @default.
• W2113884612 hasLocation W21138846124 @default.
• W2113884612 hasLocation W21138846125 @default.
• W2113884612 hasLocation W21138846126 @default.
• W2113884612 hasLocation W21138846127 @default.
• W2113884612 hasOpenAccess W2113884612 @default.
• W2113884612 hasPrimaryLocation W21138846121 @default.
• W2113884612 hasRelatedWork W2090763189 @default.
• W2113884612 hasRelatedWork W2154948599 @default.
• W2113884612 hasRelatedWork W2516062397 @default.
• W2113884612 hasRelatedWork W2792916732 @default.
• W2113884612 hasRelatedWork W2793335702 @default.
• W2113884612 hasRelatedWork W2913113213 @default.
• W2113884612 hasRelatedWork W2914671834 @default.
• W2113884612 hasRelatedWork W3114266572 @default.
• W2113884612 hasRelatedWork W4210646467 @default.

• next